Immunotherapy of inflammatory myopathies: practical approach and future prospects.

@article{Dalakas2011ImmunotherapyOI,
  title={Immunotherapy of inflammatory myopathies: practical approach and future prospects.},
  author={Marinos C. Dalakas},
  journal={Current treatment options in neurology},
  year={2011},
  volume={13 3},
  pages={311-23}
}
OPINION STATEMENT The inflammatory myopathies, a group of chronic myopathic conditions, are potentially treatable, so proper diagnosis and early initiation of therapy are necessary. The most common types are polymyositis (PM), dermatomyositis (DM), necrotizing autoimmune myopathy (NAM), and inclusion body myositis (IBM). This review provides practical advice on treatment and identifies emerging new therapies. Although IBM is difficult to treat, PM, DM, and NAM respond to appropriate… CONTINUE READING
14 Citations
52 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 52 references

An update on inflammatory and auto - immune myopathies

  • MC Dalakas
  • Neuropath Appl Neurobiol
  • 2010

Clinical applications of intravenous immunoglobulins in neurology

  • Hughes RAC, MC Dalakas, DR Cornblath
  • Clin Exp Immunol
  • 2009

Dermato - myositis with inclusion body myositis pathology

  • R vLayzer, HS Lee, D Iverson, M Margeta
  • Muscle Nerve
  • 2009

Alem - tuzumab ( Campath ) in the treatment of refractory polynyositis

  • B Thomson, P Corris, Miller JAL, RG Cooper
  • J Rheumatol
  • 2008

Similar Papers

Loading similar papers…